Principal Investment Grade Corporate Active ETF (IG)

IGI Laboratories Inc. (IG) was a specialty generic pharmaceutical company that developed and marketed topical pharmaceutical products for the treatment of various skin conditions. The company was acquired by Teligent Inc. in 2016 and is no longer publicly traded.

Therefore, there is no current market capitalization or stock price information available for IG.

Investing in IG is no longer possible, as the company was acquired and is no longer publicly traded. Investors interested in the pharmaceutical industry may consider other publicly traded companies in the sector. However, any investment carries risks, including risks associated with fluctuations in the stock market and the performance of the underlying assets.